FSMAX | OTCGX | FSMAX / OTCGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 20 years | - |
Gain YTD | 2.080 | 1.869 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.8B | 15.2B | 268% |
Annual Yield % from dividends | 1.10 | 0.00 | - |
Returns for 1 year | 23.81 | 8.95 | 266% |
Returns for 3 years | 9.90 | -7.71 | -129% |
Returns for 5 years | 49.77 | 27.26 | 183% |
Returns for 10 years | 88.32 | 86.96 | 102% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RDVY | 59.66 | 0.67 | +1.14% |
First Trust Rising Dividend Achiev ETF | |||
EEMX | 32.52 | 0.26 | +0.79% |
SPDR® MSCI Em Mkts Fssl Ful Free RsrvETF | |||
PBE | 67.63 | 0.52 | +0.77% |
Invesco Biotechnology & Genome ETF | |||
BSJQ | 23.35 | 0.04 | +0.17% |
Invesco BulletShares 2026 HY Corp Bd ETF | |||
BBIB | 96.19 | -0.06 | -0.06% |
JPMorgan BetaBuilders U.S.TrsBd3-10YrETF |